Asthma, COPD and overlap syndrome: A longitudinal study in young European adults

European Respiratory Journal

Volumn 46, Issue 3, 2015, Pages 671-679

  De Marco, Roberto ^a   Marcon, Alessandro ^a   Rossi, Andrea ^b   Antó, Josep M ^c,d,e,f   Cerveri, Isa ^g   Gislason, Thorarinn ^h   Heinrich, Joachim ^i,j   Janson, Christer ^k   Jarvis, Deborah ^l   Kuenzli, Nino ^m,n   Leynaert, Bénédicte ^o   Probst Hensch, Nicole ^m,n   Svanes, Cecilie ^p,q   Wjst, Matthias ^i,r   Burney, Peter ^l  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e UNIVERSITAT POMPEU FABRA   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g UNIVERSITY OF PAVIA   (Italy)

^h LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

ⁱ INSTITUTE OF EPIDEMIOLOGY   (Germany)

^j LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^k UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^l NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^m SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

ⁿ UNIVERSITY OF BASEL   (Switzerland)

^o INSERM   (France)

^p UNIVERSITY OF BERGEN   (Norway)

^q HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^r TECHNICAL UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ASTHMA CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME; CHILDHOOD DISEASE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE SEVERITY; DYSPNEA; ECZEMA; EUROPEAN; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; ONSET AGE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK FACTOR; SENSITIZATION; SMOKING; WHEEZING; YOUNG ADULT; AGE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; EUROPE; LUNG FUNCTION TEST; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PHYSIOLOGY; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENT DISEASE; RISK ASSESSMENT; SEX RATIO; SPIROMETRY; STATISTICAL MODEL; SURVIVAL RATE; SYNDROME; VITAL CAPACITY;

ADULT; AGE DISTRIBUTION; ASTHMA; EUROPE; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENCE; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; SEX DISTRIBUTION; SPIROMETRY; SURVIVAL RATE; SYNDROME; VITAL CAPACITY; YOUNG ADULT;

EID: 84942801919     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00008615     Document Type: Article

References (38)

1. Bahadori K, Doyle-Waters MM, Marra C, et al. Economic burden of asthma: a systematic review. BMC Pulm Med 2009; 9: 24.
2. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html/ Date last accessed: April 8, 2015. Date last updated: January 2015.
3. de Marco R, Cappa V, Accordini S, et al. Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J 2012; 39: 883-892.
4. Gershon A, Guan J, Victor JC, et al. Quantifying health service use for chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187: 596-601.
5. de Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One 2013; 8: e62985.
6. Hersh CP, Jacobson FL, Gill R, et al. Computed tomography phenotypes in severe, early-onset chronic obstructive pulmonary disease. COPD 2007; 4: 331-337.
7. Louie S, Zeki AA, Schivo M, et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev Clin Pharmacol 2013; 6: 197-219.
8. Contoli M, Baraldo S, Marku B, et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. J Allergy Clin Immunol 2010; 125: 830-837.
9. Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir Res 2011; 12: 127.
10. Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma 2011; 48: 279-285.
11. Soriano JB, Davis KJ, Coleman B, et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003; 124: 474-481.
12. Zeki AA, Schivo M, Chan A, et al. The asthma-COPD overlap syndrome: a common clinical problem in the elderly. J Allergy (Cairo) 2011; 2011: 861926.
13. Al-Kassimi FA, Alhamad EH. A challenge to the seven widely believed concepts of COPD. Int J Chron Obstruct Pulmon Dis 2013; 8: 21-30.
14. Viegi G, Matteelli G, Angino A, et al. The proportional Venn diagram of obstructive lung disease in the Italian general population. Chest 2004; 126: 1093-1101.
15. de Marco R, Accordini S, Cerveri I, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 2007; 175: 32-39.
16. Burney PG, Luczynska C, Chinn S, et al. The European Community Respiratory Health Survey. Eur Respir J 1994; 7: 954-960.
17. European Community Respiratory Health Survey II Steering Committee. The European Community Respiratory Health Survey II. Eur Respir J 2002; 20: 1071-1079.
18. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
19. Cerveri I, Corsico AG, Accordini S, et al. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax 2008; 63: 1040-1045.
20. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5-40.
21. Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011; 365: 1184-1192.
22. Marcon A, Corsico A, Cazzoletti L, et al. Body mass index, weight gain, and other determinants of lung function decline in adult asthma. J Allergy Clin Immunol 2009; 123: 1069-1074.
23. Burney P. Variable loss of lung function in COPD. N Engl J Med 2011; 365: 1246-1247.
24. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64: 728-735.
25. Piras B, Miravitlles M. The overlap phenotype: the (missing) link between asthma and COPD. Multidiscip Respir Med 2012; 7: 8.
26. Svanes C, Sunyer J, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010; 65: 14-20.
27. Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160: 1683-1689.
28. Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airflow obstruction. Thorax 1984; 39: 131-136.
29. de Marco R, Accordini S, Marcon A, et al. Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit Care Med 2011; 183: 891-897.
30. Panettieri RA Jr, Covar R, Grant E, et al. Natural history of asthma: persistence versus progression - does the beginning predict the end? J Allergy Clin Immunol 2008; 121: 607-613.
31. Bisgaard H, Jensen SM, Bønnelykke K. Interaction between asthma and lung function growth in early life. Am J Respir Crit Care Med 2012; 185: 1183-1189.
32. Marcon A, Cerveri I, Wjst M, et al. Can an airway challenge test predict respiratory diseases? A population-based international study. J Allergy Clin Immunol 2014; 133: 104-110.
33. de Marco R, Marcon A, Jarvis D, et al. Inhaled steroids are associated with reduced lung function decline in subjects with asthma with elevated total IgE. J Allergy Clin Immunol 2007; 119: 611-617.
34. Fu JJ, Gibson PG, Simpson JL, et al. Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome. Respiration 2014; 87: 63-74.
35. Andersén H, Lampela P, Nevanlinna A, et al. High hospital burden in overlap syndrome of asthma and COPD. Clin Respir J 2013; 7: 342-346.
36. Campo P, Rodríguez F, Sánchez-García S, et al. Phenotypes and endotypes of uncontrolled severe asthma: new treatments. J Investig Allergol Clin Immunol 2013; 23: 76-88.
37. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128-1138.
38. de Marco R, Accordini S, Antò JM, et al. Long-term outcomes in mild/moderate chronic obstructive pulmonary disease in the European Community Respiratory Health Survey. Am J Respir Crit Care Med 2009; 180: 956-963.